Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
about
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort.Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.Detection of drug-drug interactions through data mining studies using clinical sources, scientific literature and social media.Antiretroviral Use in the CEASE Cohort Study and Implications for Direct-Acting Antiviral Therapy in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionThe majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions.Optimum combination therapy regimens for HIV/HCV infection.Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C.Influence of Ethanol on Darunavir Hepatic Clearance and Intracellular PK/PD in HIV-Infected Monocytes, and CYP3A4-Darunavir Interactions Using Inhibition and in Silico Binding Studies.High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice.Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disordersPeripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals.Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
P2860
Q33557819-B5749A85-5D71-4279-8ADC-68324FB9846EQ33699364-2E85AB30-7FBB-412D-954B-31CEA4F19D6AQ36320218-E347CAD7-05A2-4379-B8E3-7A7C675BB9D0Q37091595-90333CB3-48EA-433E-BC12-F5A6E2417125Q38621245-80288EA0-0EFB-4E33-A5AB-C7325CC0FD5BQ38715477-6F39E85E-C18C-400C-A1DD-9A046CA15A14Q38929010-EF5B5498-1861-4F6A-AD32-BCA03C941EF8Q40171626-DDEAA4E9-BD63-4AE2-9DC7-6A2BD1BE3F97Q40437474-79C40ACD-F1F1-45A5-82B4-783286606B9AQ42680423-F77CBF23-DB41-4D76-A890-8739D6113458Q44537545-2C740B4E-8F6A-4921-8B10-895F6D68AE98Q45323924-50C71004-B6B1-472D-B7BE-8108757B9A5E
P2860
Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@ast
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@en
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@nl
type
label
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@ast
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@en
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@nl
prefLabel
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@ast
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@en
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@nl
P2093
P2860
P3181
P1433
P1476
Potential for Drug-Drug Intera ...... of HIV/HCV Coinfected Patients
@en
P2093
Alissa Naqvi
Antoine Cheret
Christine Jacomet
Claudine Duvivier
Eric Billaud
Laurent Cotte
Lise Cuzin
Marc-Antoine Valantin
Pascal Pugliese
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0141164
P407
P577
2015-01-01T00:00:00Z